The 64 rating InvestorsObserver gives to Lyell Immunopharma Inc (LYEL) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 73 percent of stocks in the Biotechnology industry, LYEL’s 64 overall rating means the stock scores better than 64 percent of all stocks.
LYEL has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on LYEL!